The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...] …
Articles by : William Newton, Associate Editor/Senior Writer
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court has dismissed AIDS Healthcare Foundation’s (AHF’s) lawsuit alleging Apexus, the 340B prime vendor, failed to negotiate [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Trade groups representing pharmacists and 340B health systems have jointly released model state legislation that would prohibit drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major bipartisan Senate 340B program overhaul, called the SUSTAIN 340B Act, could be released as soon as early September [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A powerful brand name drug industry trade group has filed suit against a Kansas law prohibiting drugmaker 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Johnson & Johnson (J&J) is exempting covered entities in Maryland and Mississippi from its contract pharmacy restrictions, marking [...] …